# DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal Adenocarcinoma

> **NCT03526328** · — · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 32 (actual)

## Conditions studied

- Barrett's Esophagus
- Esophageal Adenocarcinoma

## Interventions

- **OTHER:** EMR and RFA effect on stem cell marker expression in BE/EAC

## Key facts

- **NCT ID:** NCT03526328
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2019-08-13
- **Final completion:** 2019-08-13
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526328, "DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal Adenocarcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03526328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*